Safety and Immunogenicity of a Trivalent Salmonella Conjugate Vaccine to S. Typhi, S. Typhimurium, and S. Enteritidis

Key Points

• The main aim is to assess the safety and immunogenicity of a trivalent Salmonella conjugate vaccine for significant public health issues.
• Evaluation of vaccine safety and immune response in young children
• Focus on trivalent vaccine targeting S. Typhi, S. Typhimurium, and S. Enteritidis
• Use of immunological assays to measure responses
• Encouraging safety profile with minimal adverse effects
• Demonstrated significant immune responses against all three Salmonella strains
• Promising data support further development for public health applications

Abstract